Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 29, 2025 08:12 ET | Source: Foresight Autonomous Holdings Ltd.

Foresight Selected by Car Manufacturer Audi AG to Showcase its Terrain Intelligence Technology

Next steps entail discussions on a potential POC project for integrating Foresight’s terrain intelligence into Audi’s vehicle development program Ness Ziona, Israel, Dec. 29, 2025 (GLOBE NEWSWIRE)...
December 29, 2025 06:00 ET | Source: Tower Semiconductor

Tower Semiconductor to Attend the 28th Annual Needham Growth Conference

MIGDAL HAEMEK, Israel, December 29, 2025 – Tower Semiconductor (NASDAQ/TASE: TSEM), the leading foundry of high value analog semiconductor solutions, today announced that its company representatives...
December 26, 2025 07:00 ET | Source: Can-Fite BioPharma Ltd.

Can-Fite Granted Brazilian Patent for Treatment of Sexual Dysfunction

RAMAT GAN, Israel, Dec. 26, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs...
December 24, 2025 16:00 ET | Source: XTL Biopharmaceuticals Ltd.

XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency

RAMAT GAN, ISRAEL, Dec. 24, 2025 (GLOBE NEWSWIRE) -- XTL Biopharmaceuticals Ltd. (Nasdaq:XTLB) (TASE:XTLB.TA) (the “Company” or “XTL”), announced today that it has received a notification letter...
December 24, 2025 08:36 ET | Source: Teva Pharmaceutical Industries Ltd

S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive

The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial discipline.Moody's affirmed Teva's B1a rating and revised Teva's outlook to positive from...
December 23, 2025 16:46 ET | Source: Can-Fite BioPharma Ltd.

Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change

RAMAT GAN, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs...
December 23, 2025 08:05 ET | Source: Foresight Autonomous Holdings Ltd.

Foresight Expands Road Safety Product Outreach in South Korea with a Strategic Cooperation Agreement

Ness Ziona, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, announced...
December 22, 2025 16:30 ET | Source: ZOOZ Strategy Ltd.

ZOOZ Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

TEL AVIV, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- ZOOZ Strategy Ltd. (Nasdaq and TASE: ZOOZ) (“ZOOZ” or the “Company”) announced today that the Company received a notification letter (the...
December 22, 2025 07:30 ET | Source: BrainsWay

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

BURLINGTON, Mass. and JERUSALEM, Dec. 22, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation...
December 22, 2025 07:00 ET | Source: Pluri Inc.

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

HAIFA, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for...